This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Acarin, L. Articles by Castellano, B. Search for Related Content PubMed PubMed Citation Articles by Acarin, L. Articles by Castellano, B. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Degenerative Nerve Diseases Related Collections Animal models of human disease Growth factors/cytokines Ischemic biology - basic studies Stroke in Children and the Young Neuroprotectors

(Stroke. 2002;33:2499.)
© 2002 American Heart Association, Inc.

Original Contributions

Decrease of Proinflammatory Molecules Correlates With Neuroprotective Effect of the Fluorinated Salicylate Triflusal After Postnatal Excitotoxic Damage

Laia Acarin, PhD; Berta González, PhD Bernardo Castellano, PhD

From the Unit of Histology, School of Medicine, Department of Cell Biology, Physiology, and Immunology, Autonomous University of Barcelona, Bellaterra, Spain.

Correspondence to Laia Acarin, PhD, Unitat Histologia, Facultat Medicina, Torre M5, Campus Universitat Autònoma Barcelona, Bellaterra 08193, Spain. E-mail laia.acarin{at}uab.es

Background and Purpose— The fluorinated salicylate triflusal has been shown to have a neuroprotective effect after an excitotoxic lesion to the postnatal brain. In this regard, the aim of this study was to elucidate whether neuroprotection was associated with changes in the expression of proinflammatory molecules such as interleukin-1ß (IL-1ß), tumor necrosis factor- (TNF-), inducible nitric oxide synthase (iNOS), or cyclooxygenase-2 (COX-2), well-known mediators of oxidative stress and inflammation, mechanisms underlying secondary damage occurring after excitotoxic/ischemic brain injury.

Methods— Postnatal day 9 rats received an intracortical injection of N-methyl-D-aspartate followed by oral administration of triflusal (30 mg/kg) 8 hours later. Ten or 24 hours after lesion, animals were killed, and brain sections processed for the immunohistochemical demonstration of IL-1ß, TNF-, iNOS, and COX-2.

Results— Besides a reduction in the neurodegenerative area, triflusal strongly decreased iNOS immunolabeling at both survival times analyzed, attenuating iNOS immunoreactivity in astroglial cells and infiltrated neutrophils. Additionally, a moderate reduction in COX-2, IL-1ß, and TNF- was observed. Triflusal decreased neuronal and microglial COX-2 expression at 10 and 24 hours after lesion and microglial and astroglial expression of IL-1ß and TNF- at 24 hours after lesion. TNF- expression in neuronal cells at 10 hours after lesion was, however, maintained.

Conclusions— This study suggests that triflusal neuroprotection is associated with a decrease of iNOS and other inflammatory mediators and therefore may constitute a good therapeutic agent in pathological situations in which regulation of inflammatory genes constitutes a relevant step in the outcome of the neurodegenerative event.

Key Words: astrocytes • cyclooxygenase-2 • inflammation • interleukins • microglia • nitric oxide synthase • tumor necrosis factor

This article has been cited by other articles:

				N. P. Turrin and S. Rivest Tumor Necrosis Factor {alpha} But Not Interleukin 1{beta} Mediates Neuroprotection in Response to Acute Nitric Oxide Excitotoxicity J. Neurosci., January 4, 2006; 26(1): 143 - 151. [Abstract] [Full Text] [PDF]